Cheryl Eppolito

2.2k total citations · 1 hit paper
28 papers, 1.8k citations indexed

About

Cheryl Eppolito is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Cheryl Eppolito has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 13 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Cheryl Eppolito's work include Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (7 papers). Cheryl Eppolito is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (7 papers). Cheryl Eppolito collaborates with scholars based in United States, Canada and Japan. Cheryl Eppolito's co-authors include Protul Shrikant, Kunle Odunsi, Junko Matsuzaki, Shashikant Lele, Takemasa Tsuji, Sacha Gnjatic, Austin Miller, Amy Beck, Paulette Mhawech‐Fauceglia and Lloyd J. Old and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Cheryl Eppolito

26 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

2010 695 citations Junko Matsuzaki, Sacha Gnjatic et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheryl Eppolito United States	16	1.2k	1.1k	273	112	106	28	1.8k
Emma Jones United Kingdom	26	1.7k 1.4×	942 0.8×	423 1.5×	103 0.9×	101 1.0×	52	2.3k
Dorothée Duluc France	21	1.7k 1.4×	595 0.5×	451 1.7×	95 0.8×	124 1.2×	36	2.2k
Kristin G. Anderson United States	13	1.7k 1.4×	652 0.6×	377 1.4×	124 1.1×	115 1.1×	21	2.2k
Iain Comerford Australia	25	1.3k 1.0×	874 0.8×	403 1.5×	70 0.6×	56 0.5×	42	1.9k
Inbal Mishalian Israel	18	1.7k 1.4×	867 0.8×	463 1.7×	62 0.6×	113 1.1×	26	2.4k
Alfonso R. Sánchez-Paulete Spain	21	1.5k 1.2×	1.3k 1.2×	402 1.5×	176 1.6×	120 1.1×	27	2.1k
Carl E. Ruby United States	22	1.0k 0.8×	685 0.6×	488 1.8×	163 1.5×	91 0.9×	33	1.7k
Claire N. Manzotti United Kingdom	11	1.9k 1.5×	869 0.8×	251 0.9×	215 1.9×	90 0.8×	12	2.3k
Naoko Aoki Japan	28	1.2k 1.0×	569 0.5×	510 1.9×	61 0.5×	129 1.2×	70	1.8k
Padmasini Kumar United States	16	717 0.6×	492 0.4×	516 1.9×	90 0.8×	143 1.3×	27	1.3k

Countries citing papers authored by Cheryl Eppolito

Since Specialization

Citations

This map shows the geographic impact of Cheryl Eppolito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Eppolito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Eppolito more than expected).

Fields of papers citing papers by Cheryl Eppolito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Eppolito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Eppolito. The network helps show where Cheryl Eppolito may publish in the future.

Co-authorship network of co-authors of Cheryl Eppolito

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Eppolito. A scholar is included among the top collaborators of Cheryl Eppolito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Eppolito. Cheryl Eppolito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsuji, Takemasa, Junko Matsuzaki, Hemn Mohammadpour, et al.. (2022). Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction. Cancer Immunology Immunotherapy. 71(12). 2881–2898. 4 indexed citations

McGray, AJ Robert, Cheryl Eppolito, Anthony Miliotto, et al.. (2021). A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer. Cancer Immunology Immunotherapy. 70(12). 3451–3460. 11 indexed citations

McGray, AJ Robert, Ruea-Yea Huang, Sebastiano Battaglia, et al.. (2019). Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer. Journal for ImmunoTherapy of Cancer. 7(1). 189–189. 45 indexed citations

McGray, AJ Robert, Cheryl Eppolito, Anthony Miliotto, et al.. (2017). Abstract 4557: Tumor immune profiling identifies multiple unique therapeutic targets that improve vaccination + oncolytic virotherapy against metastatic ovarian cancer. Cancer Research. 77(13_Supplement). 4557–4557.

Matsuzaki, Junko, Sacha Gnjatic, Paulette Mhawech‐Fauceglia, et al.. (2010). Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proceedings of the National Academy of Sciences. 107(17). 7875–7880. 695 indexed citations breakdown →

Shrikant, Protul, Rajesh R. Rao, Qingsheng Li, et al.. (2009). Regulating functional cell fates in CD8 T cells. Immunologic Research. 46(1-3). 12–22. 47 indexed citations

Huntoon, Kristin, Yanping Wang, Cheryl Eppolito, et al.. (2008). The acute phase protein haptoglobin regulates host immunity. Journal of Leukocyte Biology. 84(1). 170–181. 108 indexed citations

Mischo, Axel, Cheryl Eppolito, Qingsheng Li, & Protul Shrikant. (2007). Characterizing Host Immune Responses by Monitoring Fluorescently Marked Cells. Immunological Investigations. 36(5-6). 791–805. 2 indexed citations

Vingert, Benoît, Olivier Adotévi, Delphine Patin, et al.. (2006). The Shiga toxin B‐subunit targets antigen in vivo to dendritic cells and elicits anti‐tumor immunity. European Journal of Immunology. 36(5). 1124–1135. 64 indexed citations

10.

Kowalczyk, Aleksandra, Andrzej Wierzbicki, Cheryl Eppolito, et al.. (2006). Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery. The Journal of Immunology. 177(1). 177–191. 50 indexed citations

11.

Li, Qingsheng, Cheryl Eppolito, Kunle Odunsi, & Protul Shrikant. (2006). IL-12-Programmed Long-Term CD8+ T Cell Responses Require STAT4. The Journal of Immunology. 177(11). 7618–7625. 47 indexed citations

12.

Segal, Brahm H., et al.. (2006). Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. Journal of Leukocyte Biology. 80(3). 529–537. 13 indexed citations

13.

Eppolito, Cheryl, et al.. (2004). IL-21 Enhances and Sustains CD8+ T Cell Responses to Achieve Durable Tumor Immunity: Comparative Evaluation of IL-2, IL-15, and IL-21. The Journal of Immunology. 173(2). 900–909. 221 indexed citations

14.

Ehrke, M. Jane, Srđan Verstovšek, Peter Ujházy, et al.. (1998). Doxorubicin plus tumor necrosis factor α combination treatments in EL4-lymphoma-bearing C57BL/6 mice. Cancer Immunology Immunotherapy. 45(6). 287–298. 14 indexed citations

15.

Verstovšek, Srđan, Cheryl Eppolito, Peter Ujházy, et al.. (1995). Murine splenic macrophage tumoricidal activation by cytokines.. PubMed. 23(6). 519–28. 2 indexed citations

16.

Ujházy, Peter, et al.. (1994). TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cells.. PubMed. 13(2). 99–106. 4 indexed citations

17.

Maccubbin, Darbie, et al.. (1993). Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma.. PubMed. 5(9). 363–72. 19 indexed citations

18.

Ehrke, M. Jane, Carl W. Porter, Cheryl Eppolito, & Enrico Mihich. (1986). Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allografts.. PubMed. 46(6). 2798–803. 19 indexed citations

19.

Ehrke, M. Jane, et al.. (1983). The effect of PS-K, a protein bound polysaccharide, on immune responses against allogeneic antigens. International Journal of Immunopharmacology. 5(1). 35–42. 32 indexed citations

20.

Eppolito, Cheryl, et al.. (1980). Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.. PubMed. 64(2-3). 211–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact